SCHEMBL17632567

SCHEMBL17632567

Cc1noc(C)c1-c1ccc2nc(N(C#N)C(=O)[C@H]3CCNC3)sc2c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 10/20 0.47
▸ USP30 Q70CQ3 2/20 0.44
▸ CREBBP Q92793 2/20 0.39
▸ LIPG Q9Y5X9 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CLK4 Q9HAZ1 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ BRD2 P25440 5/20 0.38
▸ BRD3 Q15059 4/20 0.38
▸ MAP4K1 Q92918 1/20 0.36
▸ UCHL1 P09936 1/20 0.35
▸ ERN1 O75460 1/20 0.35
▸ PCSK9 Q8NBP7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17632023 0.93 USP30 (0.42) BRD4USP30CREBBPALDH1A1CYP1A2
SCHEMBL17632015 0.87 USP30 (0.38) BRD4USP30CREBBPALDH1A1CYP1A2
SCHEMBL17632035 0.87 ABL1 (0.45) MAP4K1
SCHEMBL17631887 0.85 USP30 (0.44) BRD4USP30MAP4K1UCHL1
SCHEMBL17632188 0.85 CYP1A2 (0.38) BRD4USP30ALDH1A1CYP1A2CLK4
SCHEMBL17631771 0.85 BRD4 (0.46) BRD4USP30CREBBPLIPGALDH1A1
SCHEMBL17631968 0.84 USP30 (0.36) BRD4USP30CREBBPALDH1A1CYP1A2
SCHEMBL17632490 0.84 MAPT (0.43) ALDH1A1LMNA
SCHEMBL17631794 0.84 USP30 (0.35) BRD4USP30ALDH1A1CYP1A2CLK4
SCHEMBL17632007 0.83 LIPG (0.41) LIPGALDH1A1LMNAMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback